QuantumDx CARB-X Awards SpeeDx up to $3.7 Million for CT/NG Test on QuantumDx Q-POC SpeeDx will develop a rapid, portable test for chlamydia and gonorrhea that can determine the latter's antimicrobial susceptibility, as well. QuantuMDx Raises $15.1M to Support Scale Up of Point-of-Care Molecular Diagnostic System The firm's CEO said that its MDx system is available for research use and going through CE-IVD marking ahead of its full commercial launch. QuantuMDx Receives CE-IVD Marking for SARS-CoV-2 Test The company said it has scaled up production capacity to two million reactions per week and has the potential to scale up to three million reactions per week. Diagnostics Firms Rush to Develop Rapid Point-of-Care Tests for Novel Coronavirus Premium A handful of rapid 2019-nCoV assays are in the works which could help triage patients more effectively and avoid unnecessary quarantines. QuantuMDx Raises $14M to Support Development of POC Genotyping Assay The company said it has started the CE mark approval process of commissioned high-risk HPV genotyping assays and expects to certify them this year. Dec 10, 2019 Ontera, QuantuMDx Partner on Sepsis Test Development Nov 7, 2019 SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs Feb 21, 2019 With Studies Underway in South America and Asia, QuantuMDx Readies POC Platform for Launch Premium Dec 21, 2018 In Brief This Week: QuantuMDx, Molbio, Seegene, Qiagen, Epigenomics, More Jan 24, 2018 QuantuMDx Raises $12M Feb 2, 2017 QuantuMDx, Global Good Partner on POC Cervical Cancer Screening in Low-Resource Settings Premium Nov 28, 2016 QuantuMDx Wins Gates Foundation Funds for Point-of-Care TB MDx Premium Jun 9, 2015 QuantuMDx, Scienion Partner to Commercialize Nanowire Biosensor Oct 28, 2014 IP Roundup: CalTech, QuantumDx, Fluidigm Win US Patents Premium Oct 28, 2014 FIND Collaborates with Multiple Firms on MDx Tests for TB Sep 16, 2014 With Handheld Test Device Prototype Ready, QuantuMDx Seeks Financing to Support Commercial Launch Premium Jul 1, 2014 People in the News: John Burn, Andrzej Jakubowiak, Shaji Kumar, Sagnar Lonial, Gareth Morgan, Antonio Palumbo, and Others Premium Jun 10, 2014 QuantuMDx to Invest in Molecular Diagnostics Pipeline, R&D Teams Following $8.4M Funding Round Premium Jun 2, 2014 QuantuMDx Raises $8.4M to Support Development of POC MDx Device Apr 2, 2014 QuantuMDx, Singapore Institute Reach Microfluidics Technology Agreement Jan 27, 2014 QuantuMDx Eyeing 2015 Launch of Handheld POC MDx Device Jan 8, 2014 People in the News: Elaine Warburton: Jan 8, 2014 Premium Jan 8, 2014 People in the News: Elaine Warburton: Jan 8, 2014 (rev. 1) Premium Jan 7, 2014 People in the News: Elaine Warburton: Jan 7, 2014 Premium Oct 23, 2013 QuantuMDx's NorthGene Accredited for UK Justice Ministry Testing Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.